Shoulder Anterior Capsular Block for Postoperative Analgesia in Arthroscopic Rotator Cuff Repair Surgery
Launched by ZAGAZIG UNIVERSITY · May 13, 2025
Trial Information
Current as of September 12, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new way to manage pain after shoulder surgery, specifically for patients undergoing arthroscopic rotator cuff repair. The researchers want to see if a technique called the ultrasound-guided Shoulder Anterior Capsular (SHAC) block can effectively reduce pain and improve recovery for patients. This method targets the nerves in the shoulder to provide pain relief without affecting muscle movement, which could help patients recover more quickly and comfortably.
To participate in this trial, you need to be between 21 and 60 years old and be scheduled for a specific type of shoulder surgery. You'll need to be in good overall health with a body mass index (BMI) of 30 or less. However, if you have certain health conditions, like blood clotting issues or a history of shoulder surgery, you may not be eligible. If you join the study, you can expect to receive the SHAC block during your surgery to help manage your pain afterward. This trial is still recruiting participants, so if you're interested, please talk to your doctor for more information.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients acceptance
- • Age: 21-60 years
- • Sex: both sexes (males or females).
- • Physical status: ASA 1\& II.
- • Body mass index (BMI) ≤ 30 kg/m2
- • Type of operation: arthroscopic rotator cuff repair surgery.
- • Duration of surgery: within 2 hours.
- Exclusion Criteria:
- • Patient with any contraindications of regional blocks (as coagulopathy or local infection at injection site)
- • Patients with known history of allergy to the study drugs.
- • patients with neuropathy involving the limb undergoing surgery
- • Advanced hepatic, renal, cardiovascular, and neurologic diseases.
- • history of previous shoulder operation or fracture.
- • conversion to open surgery from arthroscopy.
- • pregnant females
- • patients with chronic opioid use
About Zagazig University
Zagazig University, a prominent educational and research institution located in Egypt, plays a pivotal role in advancing medical knowledge and promoting health innovations through its clinical trials. With a commitment to excellence in research, the university leverages its diverse expertise and state-of-the-art facilities to conduct rigorous clinical studies that aim to improve patient care and outcomes. By fostering collaboration among multidisciplinary teams, Zagazig University contributes significantly to the global medical community, ensuring that its clinical trials adhere to the highest ethical standards and regulatory requirements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Zagazig, Al Sharqia, Egypt
Patients applied
Trial Officials
Shereen E. Abd Ellatif, MD
Study Director
Anaesthesia, Intensive Care, and Pain Management Department. Faculty of Medicine, Zagazig University
Sherif M. S. Mowafy, MD
Principal Investigator
Anaesthesia, Intensive Care, and Pain Management Department. Faculty of Medicine, Zagazig University
Fatma M. Ahmed, MD
Study Chair
Anaesthesia, Intensive Care, and Pain Management Department. Faculty of Medicine, Zagazig University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported